Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

ACCELERATE DIAGNOSTICS, INC.

(AXDX)
  Report
Delayed Nasdaq  -  04:00 2022-09-23 pm EDT
1.640 USD   -1.20%
09/19ACCELERATE DIAGNOSTICS, INC.(NASDAQCM : AXDX) dropped from S&P Global BMI Index
CI
08/23ACCELERATE DIAGNOSTICS, INC : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
08/19Accelerate Diagnostics Prices Underwritten Offering of Common Stock at $2/Share; Shares Sink Friday
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

ACCELERATE DIAGNOSTICS, INC : Other Events (form 8-K)

06/30/2022 | 04:15pm EDT
Item 8.01. Other Events.



As previously announced, on March 24, 2022, Accelerate Diagnostics, Inc. (the "Company") entered into a securities purchase agreement (the "Securities Purchase Agreement") with the Jack W. Schuler Living Trust (the "Schuler Trust") for the issuance and sale by the Company of an aggregate of an aggregate of 2,439,024 shares of the Company's common stock (the "Shares") to the Schuler Trust in an offering (the "Private Placement") exempt from registration pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended, and Rule 506 promulgated thereunder. Pursuant to the Securities Purchase Agreement, the closing of the Private Placement was to occur on June 30, 2022 (the "Closing Date"), subject to the satisfaction of customary closing conditions. On June 29, 2022, the Company and the Schuler Trust agreed to extend the Closing Date to September 26, 2022. All other terms of the Securities Purchase Agreement remain unchanged.

© Edgar Online, source Glimpses

All news about ACCELERATE DIAGNOSTICS, INC.
09/19ACCELERATE DIAGNOSTICS, INC.(NASDAQC : AXDX) dropped from S&P Global BMI Index
CI
08/23ACCELERATE DIAGNOSTICS, INC : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
08/19Accelerate Diagnostics Prices Underwritten Offering of Common Stock at $2/Share; Shares..
MT
08/18Accelerate Diagnostics Announces Pricing of Public Offering of Common Stock
PR
08/18SECTOR UPDATE : Health Care Stocks Unable to Reach Positive Ground
MT
08/18SECTOR UPDATE : Health Care
MT
08/18Top Midday Decliners
MT
08/18Accelerate Diagnostics Slumps After Initiating Stock Offering
MT
08/18Top Premarket Decliners
MT
08/18Accelerate Diagnostics Initiates Stock Offering
MT
More news
Analyst Recommendations on ACCELERATE DIAGNOSTICS, INC.
More recommendations
Financials (USD)
Sales 2022 14,4 M - -
Net income 2022 -56,9 M - -
Net Debt 2022 - - -
P/E ratio 2022 -2,01x
Yield 2022 -
Capitalization 162 M 162 M -
Capi. / Sales 2022 11,3x
Capi. / Sales 2023 9,08x
Nbr of Employees 220
Free-Float 73,4%
Chart ACCELERATE DIAGNOSTICS, INC.
Duration : Period :
Accelerate Diagnostics, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ACCELERATE DIAGNOSTICS, INC.
Short TermMid-TermLong Term
TrendsBearishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 2
Last Close Price 1,64 $
Average target price 4,00 $
Spread / Average Target 144%
EPS Revisions
Managers and Directors
Jack Phillips President, Chief Executive Officer & Director
Steven Reichling Chief Financial & Accounting Officer
John Patience Chairman
Lawrence Mertz Chief Technology Officer
Jack W. Schuler Independent Director
Sector and Competitors